4.5 Article

Persistent metagenomic signatures of early-life hospitalization and antibiotic treatment in the infant gut microbiota and resistome

Journal

NATURE MICROBIOLOGY
Volume 4, Issue 12, Pages 2285-2297

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41564-019-0550-2

Keywords

-

Categories

Funding

  1. National Institute of General Medical Sciences of the National Institutes of Health [R01 GM099538]
  2. National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01 AI123394]
  3. US Centers for Disease Control and Prevention [200-2016-91955]
  4. National Institutes of Health [5P30 DK052574]
  5. Eunice Kennedy Shriver National Institute Of Child Health and Human Development of the National Institutes of Health [R01 HD092414]
  6. Children's Discovery Institute at St Louis Children's Hospital
  7. NIGMS training grant [T32 GM007067]
  8. NIDDK Pediatric Gastroenterology Research Training Program [T32 DK077653]
  9. Washington University School of Medicine

Ask authors/readers for more resources

Hospitalized preterm infants receive frequent and often prolonged exposures to antibiotics because they are vulnerable to infection. It is not known whether the short-term effects of antibiotics on the preterm infant gut microbiota and resistome persist after discharge from neonatal intensive care units. Here, we use complementary metagenomic, culture-based and machine learning techniques to study the gut microbiota and resistome of antibiotic-exposed preterm infants during and after hospitalization, and we compare these readouts to antibiotic-naive healthy infants sampled synchronously. We find a persistently enriched gastrointestinal antibiotic resistome, prolonged carriage of multidrug-resistant Enterobacteriaceae and distinct antibiotic-driven patterns of microbiota and resistome assembly in extremely preterm infants that received early-life antibiotics. The collateral damage of early-life antibiotic treatment and hospitalization in preterm infants is long lasting. We urge the development of strategies to reduce these consequences in highly vulnerable neonatal populations.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available